CELLULAR IMMUNOREGULATORY MECHANISMS IN THE CENTRAL-NERVOUS-SYSTEM - CHARACTERIZATION OF NONINFLAMMATORY AND INFLAMMATORY CEREBROSPINAL-FLUID LYMPHOCYTES

被引:23
作者
MATSUI, M
MORI, KJ
SAIDA, T
机构
[1] UTANO NATL HOSP,DEPT NEUROL,KYOTO,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT NEUROL,KYOTO 606,JAPAN
[3] NIIGATA UNIV,FAC SCI,DEPT BIOL,NIIGATA 95021,JAPAN
关键词
D O I
10.1002/ana.410270611
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dual‐label flow cytometric analysis of cerebrospinal fluid (CSF) and blood lymphocytes with combinations of monoclonal antibodies such as CD4 plus CD45R or Leu8, and CD8 plus CD11b was performed in 37 patients with noninflammatory neurological disease (NINDs) to clarify the differences in cellular immunoregulatory mechanisms present in the central nervous system (CNS) and in the systemic circulation. In the CSF of patients with NINDs, the paucity of CD4+CD45R+ and CD8+CD11b+ cells was striking, whereas the same subsets accounted for substantial proportions in the blood. CD4+CD45R− and CD4+Leu8− cells as well as CD8+CD11b− cells increased in the CSF when compared with those in the blood. Seven patients with active multiple sclerosis (MS) and 10 patients with other inflammatory diseases in the CNS(CNS‐infl) were also studied. Patients with active MS were characterized by a consistent increase in percentage of CD4+CD45R− cells in the CSF, whereas an increase of CD4−CD45R+ cells in the CSF was a feature of the patients with CNS‐infl, when compared with patients with NINDs. These findings indicate that the CNS is routinely surveyed by particular subsets of lymphocytes different from those in the blood, and cellular immune reaction in the CNS varies according to the types of CNS inflammatory conditions. Copyright © 1990 American Neurological Association
引用
收藏
页码:647 / 651
页数:5
相关论文
共 29 条
[1]  
AKBAR AN, 1988, J IMMUNOL, V140, P2171
[2]   CHARACTERIZATION OF HUMAN-LYMPHOCYTE SUBPOPULATIONS - ALLOREACTIVE CYTO-TOXIC LYMPHOCYTE-T PRECURSOR AND EFFECTOR-CELLS ARE PHENOTYPICALLY DISTINCT FROM LEU-2+ SUPPRESSOR CELLS [J].
CLEMENT, LT ;
DAGG, MK ;
LANDAY, A .
JOURNAL OF CLINICAL IMMUNOLOGY, 1984, 4 (05) :395-402
[3]  
CLEMENT LT, 1988, J IMMUNOL, V141, P1464
[4]  
DAMLE NK, 1984, J IMMUNOL, V132, P644
[5]   2 SUBSETS OF HUMAN CD4+ T-HELPER CELLS DIFFERING IN KINETICS AND CAPACITIES TO PRODUCE INTERLEUKIN-2 AND INTERFERON-GAMMA CAN BE DEFINED BY THE LEU-18 AND UCHL1 MONOCLONAL-ANTIBODIES [J].
DOHLSTEN, M ;
HEDLUND, G ;
SJOGREN, HO ;
CARLSSON, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (08) :1173-1178
[6]   INVIVO ACTIVATED LYMPHOCYTES-T IN THE PERIPHERAL-BLOOD AND CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS [J].
HAFLER, DA ;
FOX, DA ;
MANNING, ME ;
SCHLOSSMAN, SF ;
REINHERZ, EL ;
WEINER, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (22) :1405-1411
[7]   T-CELLS IN MULTIPLE-SCLEROSIS AND INFLAMMATORY CENTRAL NERVOUS-SYSTEM DISEASES [J].
HAFLER, DA ;
WEINER, HL .
IMMUNOLOGICAL REVIEWS, 1987, 100 :307-332
[8]  
HAFLER DA, 1986, J IMMUNOL, V137, P414
[9]   DUAL-LABEL IMMUNOCYTOCHEMISTRY OF THE ACTIVE MULTIPLE-SCLEROSIS LESION - MAJOR HISTOCOMPATIBILITY COMPLEX AND ACTIVATION ANTIGENS [J].
HAYASHI, T ;
MORIMOTO, C ;
BURKS, JS ;
KERR, C ;
HAUSER, SL .
ANNALS OF NEUROLOGY, 1988, 24 (04) :523-531
[10]  
HEDLUND G, 1989, IMMUNOLOGY, V66, P49